Financhill
Back

Rhythm Pharmaceuticals Quote, Financials, Valuation and Earnings

Rhythm Pharmaceuticals Price Quote

$59.94

Rhythm Pharmaceuticals Key Stats

Buy
81
Rhythm Pharmaceuticals (RYTM) is a Buy

Day range:
$59.00 - $60.25
52-week range:
$31.53 - $68.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.17
P/B ratio:
328.47%

Volume:
294.7K
Avg. volume:
569.3K
1-year change:
78.77%
Market cap:
$3.7B
Revenue:
$77.4M
EPS:
$-4.33

How Much Does Rhythm Pharmaceuticals Make?

Is Rhythm Pharmaceuticals Growing As A Company?

Rhythm Pharmaceuticals Stock Price Performance

What Is Rhythm Pharmaceuticals 52-Week High & Low?

Rhythm Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rhythm Pharmaceuticals?

Is Rhythm Pharmaceuticals Cash Flow Positive?

  • What Is RYTM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$124.4M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $155.3M
  • What Is Rhythm Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$46.7M

Rhythm Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RYTM return on invested capital is -208.96%
  • What Is Rhythm Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -76.55%
  • What Is RYTM Return On Equity?
    ROE is a measure of profitability and is -208.96%

Rhythm Pharmaceuticals Earnings Date & Stock Price

Rhythm Pharmaceuticals Competitors

Rhythm Pharmaceuticals Dividend Yield

Rhythm Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 15.95%
Revenue: 47.76% 2.42%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 70.27
Upside from Last Price: 17.24%

Major Shareholders

  • How many RYTM shares are owned by institutional investors?
    106.4M RYTM shares are owned by institutional investors
  • How many RYTM shares are owned by insiders?
    1.1M RYTM shares are owned by insiders